It has been reported that HBx promoted a CD44+CD133+ CSCs subset in malignant transformed L-02 cells and Huh7 cells, and HBx regulated tumorigenicity, self-renewal, and drug resistance in HCC cells [4,35,36]. This evidence concerns the gene CD44 and hepatocellular carcinoma.